231 related articles for article (PubMed ID: 34395283)
21. Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3).
Jia Y; Lin D; Wang Z; Li C; Wang H; Wang J; Mi Y
Diagn Pathol; 2022 Oct; 17(1):74. PubMed ID: 36199105
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Significance of
Qin YZ; Jiang Q; Xu LP; Wang Y; Jiang H; Dao FT; Chen WM; Zhao XS; Liu YR; Zhang XH; Liu KY; Huang XJ
Front Oncol; 2021; 11():632532. PubMed ID: 33816270
[TBL] [Abstract][Full Text] [Related]
23. Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With
Takeda R; Yokoyama K; Fukuyama T; Kawamata T; Ito M; Yusa N; Kasajima R; Shimizu E; Ohno N; Uchimaru K; Yamaguchi R; Imoto S; Miyano S; Tojo A
Front Oncol; 2022; 12():799982. PubMed ID: 35402256
[TBL] [Abstract][Full Text] [Related]
24. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
[TBL] [Abstract][Full Text] [Related]
25. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
[TBL] [Abstract][Full Text] [Related]
26. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
[TBL] [Abstract][Full Text] [Related]
27. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
Yaguchi A; Ishibashi T; Terada K; Ueno-Yokohata H; Saito Y; Fujimura J; Shimizu T; Ohki K; Manabe A; Kiyokawa N
Int J Hematol; 2017 Aug; 106(2):269-281. PubMed ID: 28378055
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
[TBL] [Abstract][Full Text] [Related]
29. Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL
Weinberg OK; Dennis J; Zia H; Chen P; Chu A; Koduru P; Luu HS; Fuda F; Chen W
Int J Lab Hematol; 2023 Apr; 45(2):170-178. PubMed ID: 36325594
[TBL] [Abstract][Full Text] [Related]
30. Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia.
Horvat NP; Logothetis CN; Zhang L; Yun S; Sweet K
Cureus; 2022 Mar; 14(3):e23618. PubMed ID: 35505715
[TBL] [Abstract][Full Text] [Related]
31. Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report.
Li MY; Lin ZH; Hu MM; Kang LQ; Wu XX; Chen QW; Kong X; Zhang J; Qiu HY; Wu DP
Biomark Res; 2020; 8():36. PubMed ID: 32874588
[TBL] [Abstract][Full Text] [Related]
32. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract][Full Text] [Related]
33. [The Application of RNA-Sequencing in Pediatric B-Cell Acute Lymphoblastic Leukemia].
Zou PL; Liao X; Xiao JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1700-1707. PubMed ID: 36476892
[TBL] [Abstract][Full Text] [Related]
34. Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.
Semchenkova A; Mikhailova E; Komkov A; Gaskova M; Abasov R; Matveev E; Kazanov M; Mamedov I; Shmitko A; Belova V; Miroshnichenkova A; Illarionova O; Olshanskaya Y; Tsaur G; Verzhbitskaya T; Ponomareva N; Bronin G; Kondratchik K; Fechina L; Diakonova Y; Vavilova L; Myakova N; Novichkova G; Maschan A; Maschan M; Zerkalenkova E; Popov A
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409391
[TBL] [Abstract][Full Text] [Related]
35. A novel class of ZNF384 aberrations in acute leukemia.
Zaliova M; Winkowska L; Stuchly J; Fiser K; Triska P; Zwyrtkova M; Hrusak O; Starkova J; Sramkova L; Stary J; Trka J; Zuna J
Blood Adv; 2021 Nov; 5(21):4393-4397. PubMed ID: 34529760
[TBL] [Abstract][Full Text] [Related]
36. Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a
Brethon B; Lainey E; Caye-Eude A; Grain A; Fenneteau O; Yakouben K; Roupret-Serzec J; Le Mouel L; Cavé H; Baruchel A
Front Oncol; 2021; 11():637951. PubMed ID: 33718232
[TBL] [Abstract][Full Text] [Related]
37. The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Alexander TB; Gu Z; Iacobucci I; Dickerson K; Choi JK; Xu B; Payne-Turner D; Yoshihara H; Loh ML; Horan J; Buldini B; Basso G; Elitzur S; de Haas V; Zwaan CM; Yeoh A; Reinhardt D; Tomizawa D; Kiyokawa N; Lammens T; De Moerloose B; Catchpoole D; Hori H; Moorman A; Moore AS; Hrusak O; Meshinchi S; Orgel E; Devidas M; Borowitz M; Wood B; Heerema NA; Carrol A; Yang YL; Smith MA; Davidsen TM; Hermida LC; Gesuwan P; Marra MA; Ma Y; Mungall AJ; Moore RA; Jones SJM; Valentine M; Janke LJ; Rubnitz JE; Pui CH; Ding L; Liu Y; Zhang J; Nichols KE; Downing JR; Cao X; Shi L; Pounds S; Newman S; Pei D; Guidry Auvil JM; Gerhard DS; Hunger SP; Inaba H; Mullighan CG
Nature; 2018 Oct; 562(7727):373-379. PubMed ID: 30209392
[TBL] [Abstract][Full Text] [Related]
38. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
[TBL] [Abstract][Full Text] [Related]
39. Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia.
Wu Z; Zhang F; Liu C; Shen S; Chu J; Yang L; Xie Z; Liu Y; Liu K; Wang N
Front Oncol; 2022; 12():900054. PubMed ID: 36052266
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of Clinical Characteristics of Acute B Lymphoblastic Leukemia with EP300-ZNF384 Fusion Gene Positive].
Yao ZL; Li YF; Li M; Li Y; Li WJ; Li HH; Liu YY; Lin SH; Li FW; Zhang J; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):24-28. PubMed ID: 32027248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]